Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screening

Abstract

The costs of home care in the Netherlands are estimated for women with advanced breast and cervical cancer. We observe a growing role of intensive home care for the terminally ill patients. The average costs of home care are dfl 8,500 per patient for breast cancer patients and dfl 7,200 for cervical cancer patients. More than half of these costs are incurred in the last month before death. The level of home care in the preceding months is quite modest (dfl 120 per month for both diseases), not taking into account informal care. The costs of home care for patients with advanced cancer are only slightly related to the site of the primary tumor from which the metastases originate. Total average costs per patient during advanced disease, including hospital and nursing home care, amount to dfl 42,700 for breast cancer and dfl 29,000 for cervical cancer. This difference in costs is largely attributable to the longer duration of advanced disease for breast cancer, which substantially affects hospital costs. The high costs of care to patients with advanced cancer contribute to a favourable cost-effectiveness ratio of those screening programmes which reduce mortality and consequently the costs of care to advanced cancer patients.

Assessment of Quality of Life of Cervical Cancer Patients Using ECOG-Performance Status Scale

“…In the present study, out of 218 members of cervical cancer patients, 189 (86.7%) were alive and 29 (13.3%) were deceased. The death rate in current study was less than the annual death rate 27%, reported by the researchers Marc A. Koopmanschap et al [30]. The mean age of death in cervical cancer patients found to be 60.1±13 years where, a study conducted by Irving ER et al in suriname, reported the mean age of death due to cervical cancer as 58 ± 15 years [31].…”

Assessment of Quality of Life of Cervical Cancer Patients Using ECOG-Performance Status Scale

“…In the present study, out of 218 members of cervical cancer patients, 189 (86.7%) were alive and 29 (13.3%) were deceased. The death rate in current study was less than the annual death rate 27%, reported by the researchers Marc A. Koopmanschap et al [30]. The mean age of death in cervical cancer patients found to be 60.1±13 years where, a study conducted by Irving ER et al in suriname, reported the mean age of death due to cervical cancer as 58 ± 15 years [31].…”

Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation

“…Standard charges were used for laboratory investigations and for an electrocardiogram. The unit price of professional domiciliary care was retrieved from the literature (10). Unit prices of oral anticoagulant treatment provided by the Dutch Thrombosis Services and unit prices of the management of thrombotic and bleeding events were retrieved from a report on an earlier study in the same hospital.…”

“…The price of a telephone call by a senior house officer was 11 NLG. For one hour of professional domiciliary care, a price of 75 NLG was used (10). The cost of the oral anticoagulant treatment provided by the Dutch Thrombosis Service was 42 NLG per month.…”

Costos y calidad de la prueba de detección oportuna del cáncer cervicouterino en una clínica pública y en una organización no gubernamental

“…De hecho, Brown y Garber 4 encontraron que el aumento reciente en la sensibilidad de la prueba de Papanicolaou la ha hecho todavía más costo-efectiva. Koopmanschap y colaboradores, 5 en un estudio realizado en Holanda, concluyeron que la detección oportuna es una acción costo-efectiva si se la compara con no realizarla y tener que atender a una mujer con CaCu avanzado. Mandelblatt y Fahs, 6 por su parte, realizaron un estudio en mujeres mayores de 65 años, de bajos ingresos, en EUA, y concluyeron, también, que el programa de detección oportuna en esta población disminuye los costos de la atención y ahorra recursos en el futuro.…”

Assessment of Quality of Life of Cervical Cancer Patients Using ECOG-Performance Status Scale

“…In the present study, out of 218 members of cervical cancer patients, 189 (86.7%) were alive and 29 (13.3%) were deceased. The death rate in current study was less than the annual death rate 27%, reported by the researchers Marc A. Koopmanschap et al [30]. The mean age of death in cervical cancer patients found to be 60.1±13 years where, a study conducted by Irving ER et al in suriname, reported the mean age of death due to cervical cancer as 58 ± 15 years [31].…”

Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation

“…Standard charges were used for laboratory investigations and for an electrocardiogram. The unit price of professional domiciliary care was retrieved from the literature (10). Unit prices of oral anticoagulant treatment provided by the Dutch Thrombosis Services and unit prices of the management of thrombotic and bleeding events were retrieved from a report on an earlier study in the same hospital.…”

“…The price of a telephone call by a senior house officer was 11 NLG. For one hour of professional domiciliary care, a price of 75 NLG was used (10). The cost of the oral anticoagulant treatment provided by the Dutch Thrombosis Service was 42 NLG per month.…”

Costos y calidad de la prueba de detección oportuna del cáncer cervicouterino en una clínica pública y en una organización no gubernamental

“…De hecho, Brown y Garber 4 encontraron que el aumento reciente en la sensibilidad de la prueba de Papanicolaou la ha hecho todavía más costo-efectiva. Koopmanschap y colaboradores, 5 en un estudio realizado en Holanda, concluyeron que la detección oportuna es una acción costo-efectiva si se la compara con no realizarla y tener que atender a una mujer con CaCu avanzado. Mandelblatt y Fahs, 6 por su parte, realizaron un estudio en mujeres mayores de 65 años, de bajos ingresos, en EUA, y concluyeron, también, que el programa de detección oportuna en esta población disminuye los costos de la atención y ahorra recursos en el futuro.…”

Assessment of Quality of Life of Cervical Cancer Patients Using ECOG-Performance Status Scale

“…In the present study, out of 218 members of cervical cancer patients, 189 (86.7%) were alive and 29 (13.3%) were deceased. The death rate in current study was less than the annual death rate 27%, reported by the researchers Marc A. Koopmanschap et al [30]. The mean age of death in cervical cancer patients found to be 60.1±13 years where, a study conducted by Irving ER et al in suriname, reported the mean age of death due to cervical cancer as 58 ± 15 years [31].…”

Replacing Inpatient Care by Outpatient Care in the Treatment of Deep Venous Thrombosis – An Economic Evaluation

“…Standard charges were used for laboratory investigations and for an electrocardiogram. The unit price of professional domiciliary care was retrieved from the literature (10). Unit prices of oral anticoagulant treatment provided by the Dutch Thrombosis Services and unit prices of the management of thrombotic and bleeding events were retrieved from a report on an earlier study in the same hospital.…”

“…The price of a telephone call by a senior house officer was 11 NLG. For one hour of professional domiciliary care, a price of 75 NLG was used (10). The cost of the oral anticoagulant treatment provided by the Dutch Thrombosis Service was 42 NLG per month.…”

Costos y calidad de la prueba de detección oportuna del cáncer cervicouterino en una clínica pública y en una organización no gubernamental

“…De hecho, Brown y Garber 4 encontraron que el aumento reciente en la sensibilidad de la prueba de Papanicolaou la ha hecho todavía más costo-efectiva. Koopmanschap y colaboradores, 5 en un estudio realizado en Holanda, concluyeron que la detección oportuna es una acción costo-efectiva si se la compara con no realizarla y tener que atender a una mujer con CaCu avanzado. Mandelblatt y Fahs, 6 por su parte, realizaron un estudio en mujeres mayores de 65 años, de bajos ingresos, en EUA, y concluyeron, también, que el programa de detección oportuna en esta población disminuye los costos de la atención y ahorra recursos en el futuro.…”